```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4120 Engrossed in Senate (ES)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
117th CONGRESS
  2d Session
                                S. 4120

_______________________________________________________________________

                                 AN ACT

 
To maximize discovery, and accelerate development and availability, of 
     promising childhood cancer treatments, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Childhood Cancer Survivorship, 
Treatment, Access, and Research Reauthorization Act of 2022'' or the 
``Childhood Cancer STAR Reauthorization Act''.

SEC. 2. REAUTHORIZING AND IMPROVING THE CHILDHOOD STAR ACT.

    (a) Children's Cancer Biorepositories.--Section 417E of the Public 
Health Service Act (42 U.S.C. 285a-11) is amended--
            (1) in subsection (a)--
                    (A) in paragraph (2)(A), by inserting before the 
                period at the end of the second sentence the following: 
                ``, such as collected samples of both solid tumor 
                cancer and paired samples'';
                    (B) in paragraph (9), by striking ``Childhood 
                Cancer Survivorship, Treatment, Access, and Research 
                Act of 2018'' and inserting ``Childhood Cancer 
                Survivorship, Treatment, Access, and Research 
                Reauthorization Act of 2022'';
                    (C) by redesignating paragraph (10) as paragraph 
                (11); and
                    (D) by inserting after paragraph (9) the following:
            ``(10) Report on researcher access to children's cancer 
        biorepository samples.--Not later than 2 years after the date 
        of enactment of the Childhood Cancer Survivorship, Treatment, 
        Access, and Research Reauthorization Act of 2022, the Director 
        of NIH shall--
                    ``(A) conduct a review of the procedures 
                established under paragraph (2)(C) and other policies 
                or procedures related to researcher access to such 
                biospecimens to identify any opportunities to reduce 
                administrative burden, consistent with paragraph 
                (2)(D), in a manner that protects personal privacy to 
                the extent required by applicable Federal and State 
                privacy law, at a minimum; and
                    ``(B) submit to the Committee on Health, Education, 
                Labor, and Pensions of the Senate and the Committee on 
                Energy and Commerce of the House of Representatives a 
                report on the findings of the review under subparagraph 
                (A) and whether the Director of NIH plans to make any 
                changes to the policies or procedures considered in 
                such review, based on such findings.''; and
            (2) in subsection (d), by striking ``2019 through 2023'' 
        and inserting ``2024 through 2028''.
    (b) Cancer Survivorship Programs.--Section 201 of the Childhood 
Cancer Survivorship, Treatment, Access, and Research Act of 2018 
(Public Law 115-180) is amended--
            (1) in subsection (a)--
                    (A) in the subsection heading, by striking ``Pilot 
                Programs to Explore'' and inserting ``Research to 
                Evaluate''
                    (B) in paragraph (1)--
                            (i) by striking ``may make awards to 
                        eligible entities to establish pilot programs'' 
                        and inserting ``shall, as appropriate, make 
                        awards to eligible entities to conduct or 
                        support research'';
                            (ii) by striking ``model systems'' and 
                        inserting ``approaches'';
                            (iii) by inserting ``and adolescent'' after 
                        ``childhood''; and
                            (iv) by striking ``evaluation of models 
                        for'';
                    (C) in paragraph (2)--
                            (i) in subparagraph (A), in the matter 
                        preceding clause (i), by inserting ``within the 
                        existing peer review process,'' after 
                        ``practicable,''; and
                            (ii) in subparagraph (B)(v), by striking 
                        ``in treating survivors of childhood cancers'' 
                        and inserting ``in carrying out the activities 
                        described in paragraph (1)''; and
                    (D) in paragraph (3)(B)(v), by striking ``design of 
                systems for the effective transfer of treatment 
                information and care summaries from cancer care 
                providers to other health care providers'' and 
                inserting ``design tools to support the secure 
                electronic transfer of treatment information and care 
                summaries between health care providers or, as 
                applicable and appropriate, longitudinal childhood 
                cancer survivorship cohorts''; and
            (2) in subsection (b)--
                    (A) in each of paragraphs (1) and (2), by striking 
                ``date of enactment of this Act'' and inserting ``date 
                of enactment of the Childhood Cancer Survivorship, 
                Treatment, Access, and Research Reauthorization Act of 
                2022''; and
                    (B) in paragraph (1)--
                            (i) by striking subparagraphs (A) and (C);
                            (ii) by redesignating subparagraph (B) as 
                        subparagraph (A); and
                            (iii) by adding at the end the following:
                    ``(B) recommendations for enhancing or promoting 
                activities of the Department of Health and Human 
                Services related to workforce development for health 
                care providers who provide psychosocial care to 
                pediatric cancer patients and survivors.''.

            Passed the Senate December 20, 2022.

            Attest:

                                                             Secretary.
117th CONGRESS

  2d Session

                                S. 4120

_______________________________________________________________________

                                 AN ACT

To maximize discovery, and accelerate development and availability, of 
     promising childhood cancer treatments, and for other purposes.
```